Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors” - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors”

  • January 22, 2026

Share

  • 1

    The erratum addresses an error in the author list of the article on the PANOMEN-3 predictive model.

  • 2

    Julia García Arabehety's name was incorrectly published as 'Julia García' in the original article.

  • 3

    The corrected name 'Julia García-Arabehety' has been updated in the online version of the article.

  • 4

    The original article was published in the Journal of Clinical Endocrinology and Metabolism.

  • 5

    The DOI for the corrected article remains the same: 10.1210/clinem/dgaf252.

Original Source(s)

Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors”

  • January 22, 2026

Related Content

Skin odor signatures may shift with age

Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.

TOFA may drive weight loss without reducing food intake

The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.

Menopause may be underdocumented in EHRs

Surveys captured nearly 7 times as many menopause observations as structured clinical records, with high agreement when both sources identified menopause.